Sanitas AB - Notification on material event

Sanitas, AB sells HBM Pharma s.r.o

On July 8, 2010 Lithuanian-domiciled Central and Eastern European (CEE)
specialty pharmaceutical company Sanitas, AB sold its 100% shareholding in
subsidiary HBM Pharma s.r.o in Slovakia to Latvian company Liplats 2000, SIA. 
HBM Pharma was primarily engaged in toll manufacturing activities and the
entity has been sold with all of its existing toll manufacturing contracts. As
previously announced, sales, marketing and regulatory divisions in  Slovakia
and the Czech Republic were separated from HBM Pharma and retained in Sanitas
Group prior to the divestment. 
Sanitas acquired HBM Pharma (previously named Hoechst Biotika) from Sanofi
Aventis in July 2005. The entity was integrated into Sanitas Group as a
manufacturing unit and a hub to start sales and marketing activities in
neighboring countries.This divestment will allow Sanitas to optimize its
manufacturing capacity, while freeing resources to reduce leverage, focus on
its own product portfolio and continue its roll-out of new branded generic
pharmaceuticals in its focus therapeutic niches. 

Legal and Corporate Affairs Director
Ruta Milkuviene
+370 37 22 67 25